Skip to main content

Table 2 List of BCR::ABL1 KD mutations identified in the present study that associated with TKIs resistance

From: Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study

TKI

Sensitive mutants

Resistant mutants

Imatinib

 

M244V

G250E

Y253H

E255K

T315I

F317L

E355G

F359V/C

E459K

Nilotinib

M244V

F317L

L387M

Y253H

E255K

T315I

F359V/C

Dasatinib

M244V

Y253H

F359V/C

L387M

E459K

E255K

T315I

F317L

Bosutinib

M244V

E255K

Y253H

F317L

E355G

G250E

T315I

Ponatinib

M244V

T315I

F317L

E255K